PAVM
PAVmed Inc

8,926
Mkt Cap
$9.77M
Volume
16,085.00
52W High
$26.85
52W Low
$6.00
PE Ratio
-0.54
PAVM Fundamentals
Price
$8.75
Prev Close
$9.19
Open
$9.27
50D MA
$9.54
Beta
1.23
Avg. Volume
14,948.69
EPS (Annual)
$14.88
P/B
0.84
Rev/Employee
$76,794.87
Loading...
Loading...
News
all
press releases
PAVmed Announces Reverse Stock Split
PAVmed Announces Reverse Stock Split PAVmed Announces Reverse Stock Split PR Newswire NEW YORK, Dec. 30, 2025 NEW YORK, Dec. 30, 2025 /PRNewswire/ --PAVmed Inc.(NASDAQ: PAVM) ('PAVmed' or the...
PR Newswire·16d ago
News Placeholder
More News
News Placeholder
Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection
Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection Lucid Diagnostics Announces Positive Data from the Largest Reported...
PR Newswire·1mo ago
News Placeholder
Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree
Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree PR Newswire NEW YORK, Nov. 20, 2025...
PR Newswire·2mo ago
News Placeholder
Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and...
PR Newswire·2mo ago
News Placeholder
PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results
PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results PR Newswire NEW YORK, Nov. 13, 2025...
PR Newswire·2mo ago
News Placeholder
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results PR Newswire NEW...
PR Newswire·2mo ago
News Placeholder
PAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025
PAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025 PAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025 PR Newswire NEW YORK, Oct. 30, 2025...
PR Newswire·3mo ago
News Placeholder
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025 Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025 PR Newswire...
PR Newswire·3mo ago
News Placeholder
Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit
Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit PR Newswire NEW YORK, Oct. 15, 2025 NEW YORK, Oct. 15, 2025...
PR Newswire·3mo ago
News Placeholder
PAVmed (PAVM) Upgraded to Strong Buy: Here's Why
PAVmed (PAVM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Zacks·3mo ago
<
1
2
...
>

Latest PAVM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.